This change will cut our expenses dramatically through fewer cases of high blood pressure, diabetes, and the problems that follow. That's the overall view. And he understands it 🙂
During a recent episode of the All-In Podcast, the current administrator for CMS revealed significant developments regarding GLP-1s and their pricing.